Gaziano TA - Search Results

1

Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis.

Gaziano TA, Opie LH, Weinstein MC. Gaziano TA, et al. Lancet. 2006 Aug 19;368(9536):679-86. doi: 10.1016/S0140-6736(06)69252-0. Lancet. 2006. PMID: 16920473 Free PMC article. Review.

2

Cardiovascular disease in the developing world and its cost-effective management.

Gaziano TA. Gaziano TA. Circulation. 2005 Dec 6;112(23):3547-53. doi: 10.1161/CIRCULATIONAHA.105.591792. Circulation. 2005. PMID: 16330695 Review. No abstract available.

3

Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level.

Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH. Gaziano TA, et al. Circulation. 2005 Dec 6;112(23):3569-76. doi: 10.1161/CIRCULATIONAHA.105.535922. Circulation. 2005. PMID: 16330698

4

Reducing the growing burden of cardiovascular disease in the developing world.

Gaziano TA. Gaziano TA. Health Aff (Millwood). 2007 Jan-Feb;26(1):13-24. doi: 10.1377/hlthaff.26.1.13. Health Aff (Millwood). 2007. PMID: 17211010 Free PMC article.

5

Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs.

Lim SS, Gaziano TA, Gakidou E, Reddy KS, Farzadfar F, Lozano R, Rodgers A. Lim SS, et al. Among authors: gaziano ta. Lancet. 2007 Dec 15;370(9604):2054-62. doi: 10.1016/S0140-6736(07)61699-7. Epub 2007 Dec 11. Lancet. 2007. PMID: 18063025 Review.

6

Scaling up interventions for chronic disease prevention: the evidence.

Gaziano TA, Galea G, Reddy KS. Gaziano TA, et al. Lancet. 2007 Dec 8;370(9603):1939-46. doi: 10.1016/S0140-6736(07)61697-3. Lancet. 2007. PMID: 18063028 Review.

7

Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa.

Gaziano TA. Gaziano TA. Heart. 2008 Feb;94(2):140-4. doi: 10.1136/hrt.2007.128785. Heart. 2008. PMID: 18195120 Review.

8

Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort.

Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Gaziano TA, et al. Among authors: gaziano jm. Lancet. 2008 Mar 15;371(9616):923-31. doi: 10.1016/S0140-6736(08)60418-3. Lancet. 2008. PMID: 18342687 Free PMC article.

9

Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model.

Garg P, Cohen DJ, Gaziano T, Mauri L. Garg P, et al. J Am Coll Cardiol. 2008 May 13;51(19):1844-53. doi: 10.1016/j.jacc.2008.01.042. J Am Coll Cardiol. 2008. PMID: 18466798 Free article.

10

The global cost of nonoptimal blood pressure.

Gaziano TA, Bitton A, Anand S, Weinstein MC; International Society of Hypertension. Gaziano TA, et al. J Hypertens. 2009 Jul;27(7):1472-7. doi: 10.1097/HJH.0b013e32832a9ba3. J Hypertens. 2009. PMID: 19474763

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters